Thomas J Schnitzer

Grants

Grants per year 2002 2024

• 20 Active
• 76 Finished

Grants per year

Search results

• Active

  Prot #20197268: Effects of Romosozumab on Bone Health in Women with Spinal Cord Injury and Osteoporosis

  Schnitzer, T. J.

  Amgen, Inc.

  12/21/20 → 12/21/23

  Project: Research project

• Prot #Cingal 19-01: A Randomized, Double-Blind, Placebo Controlled, Multi-Center Study of a Single Injection Cross-Linked Sodium Hyaluronate Combined with Triamcinolone Hexacetonide (Cingal) to Provide Symptomatic Relief of Osteoarthritis of the Knee

  Schnitzer, T. J.

  SynteractHCR, Inc., Anika Therapeutics, Inc.

  9/11/20 → 9/11/23

  Project: Research project

• Data Center for Acute to Chronic Pain Biosignatures

  Griffith, J. W., Schnitzer, T. J. & Apkarian, A.

  Johns Hopkins University, National Institute on Drug Abuse

  8/1/20 → 7/31/23

  Project: Research project

  • Neuroimaging
  • Metadata

• Prot #H0P-MC-CPMP: A Master Protocol for Randomized, Placebo-Controlled, Phase 2 Clinical Trials of Multiple Interventions for the Treatment of Chronic Pain

  Schnitzer, T. J.

  Lilly USA, LLC

  7/29/20 → 7/29/23

  Project: Research project

• Prot #TLC599A3005: A Phase 3, Randomized, Double-blind, Placebo- and Active-controlled Study to Evaluate the Efficacy and Safety of TLC599 in Patients with Osteoarthritis of the Knee

  Schnitzer, T. J.

  Premier Research International, LLC, Taiwan Liposome Company, Ltd

  6/25/20 → 6/25/23

  Project: Research project

• Prot #R475-OA-1816: Study to Evaluate Arthroplasty Specimens in the Phase 3 Fasinumab Program for Osteoarthritis of the Knee and Hip

  Schnitzer, T. J.

  ICON Clinical Research Limited, Regeneron Pharmaceuticals, Inc.

  5/14/19 → 5/14/22

  Project: Research project

• Prot #R475-OA-1758: A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Effects of Fasinumab on Peripheral Nerve Function in Patients with Pain due to Osteoarthritis of the Hip or Knee

  Schnitzer, T. J.

  inVentiv Health Clinical, Regeneron Pharmaceuticals, Inc.

  2/21/19 → 2/21/22

  Project: Research project

• Prot #FX006-2018-015: A Randomized, Double-Blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy and Safety of FX006 in Patients with Hip Osteoarthritis

  Schnitzer, T. J.

  Flexion Therapeutics, Inc.

  2/6/19 → 2/6/22

  Project: Research project

• Brain Pathophysiology of Osteoarthritis Pain

  Griffith, J. W., Kahnt, T., Manning, D. W., Parrish, T. B., Schnitzer, T. J. & Apkarian, A.

  National Institute of Arthritis and Musculoskeletal and Skin Diseases

  2/1/19 → 12/31/23

  Project: Research project

  • Osteoarthritis
  • Pain
  • Brain
  • Chronic Pain
  • Knee Osteoarthritis

• Prot #TGC-15302/KTG-15302: A Randomized, Double-Blind, Placebo-Controlled, Multi-Center, Phase 3 Study to Determine the Efficacy and Effectiveness of TG-C in Subjects with Kellgren and Lawrence Grade 2 or 3 Osteoarthritis of the Knee

  Schnitzer, T. J.

  Parexel, Kolon TissueGene, Inc.

  1/28/19 → 1/28/24

  Project: Research project

• Prot #CL2-201086-002/GLPG1972-CL-201: Efficacy and safety of 3 doses of S201086/GLPG1972 administered orally once daily in patients with knee osteoarthritis. A 52-week international, multi-regional, multi-center, randomized, double-blind, placebo-controll

  Schnitzer, T. J.

  Medpace Clinical Research LLC, Galapagos NV

  12/4/18 → 12/4/21

  Project: Research project

• Center for chronic pain and drug abuse

  Awatramani, R., Drenan, R. M., Graves, S. M., Griffith, J. W., Huang, L., Jovasevic, V., Martina, M., Parrish, T. B., Procissi, D., Radulovic, J., Rodes, M. E., Schnitzer, T. J., Surmeier Jr, D. J., Apkarian, A. & Miller, R. J.

  National Institute on Drug Abuse

  9/1/18 → 6/30/23

  Project: Research project

  • Chronic Pain
  • Substance-Related Disorders
  • Opioid Analgesics
  • Opioid-Related Disorders
  • Opiate Alkaloids

• Prot# BA058-05-019: A Randomized, Double-blind, Placebo-controlled, Phase 3 Multicenter Study to Evaluate the Safety and Efficacy of Abaloparatide-SC for the Treatment of Men with Osteoporosis

  Schnitzer, T. J.

  ICON Clinical Research, LLC, Radius Health, Inc.

  6/13/18 → 6/13/21

  Project: Research project

• D-Cycloserine for the Treatment of Chronic, Refractory Low Back Pain

  Griffith, J. W., Schnitzer, T. J. & Apkarian, A.

  U.S. Army Medical Research and Materiel Command

  9/30/17 → 9/29/21

  Project: Research project

  • Cycloserine
  • Low Back Pain
  • Chronic Pain
  • Back Pain
  • Pain

• Prot #KF7013-03: Open-label safety trial of intravenous neridronic acid in subjects with complex regional pain syndrome (CRPS)

  Schnitzer, T. J.

  Worldwide Clinical Trials, Inc., Grunenthal GmbH

  1/17/17 → 1/17/22

  Project: Research project

• Prot #R475-PN-1523: A Phase 3 Randomized, Double-Blind, Multi-Dose, Placebo-Controlled Study to Evaluate the Long-Term Safety and the Efficacy of Fasinumab in Patients with Pain Due to Osteoarthritis of the Knee or Hip

  Schnitzer, T. J.

  ICON Clinical Research, LLC, Regeneron Pharmaceuticals, Inc.

  5/12/16 → 5/12/22

  Project: Research project

• Prot #R475-PN-1524: A Randomized, Double-blind, Multi-dose, Placebo-controlled Phase 2/3 Study to Evaluate the Efficacy and Safety of Fasinumab in Patients with Moderate to Severe Chronic Low Back Pain

  Schnitzer, T. J.

  ICON Clinical Research, LLC, Regeneron Pharmaceuticals, Inc.

  3/10/16 → 4/15/21

  Project: Research project

• Prot #A4091059: A Phase 3, Randomized, Double Blind, Placebo and Active Controlled, Multicenter, Parallel Group Study of the Analgesic Efficacy and Safety of Tanezumab in Adult Subjects with Chronic Low Back Pain

  Schnitzer, T. J.

  INC Research, LLC, Pfizer Inc.

  9/11/15 → 9/11/21

  Project: Research project

• Prot #A4091058: A Phase 3 Randomized, Double-Blind, Active-Controlled, Multicenter Study of the Long-Term Safety and Efficacy of Subcutaneous Administration of Tanezumab in Subjects with Osteoarthritis of the Hip or Knee

  Schnitzer, T. J.

  INC Research, LLC, Pfizer Inc.

  8/25/15 → 8/31/21

  Project: Research project

• Prevention of Bone Loss after Acute SCI by Zoledronic Acid: Durability, Effect on Bone Strength and Use of Biomarkers to Guide Therapy

  Griffith, J. W. & Schnitzer, T. J.

  U.S. Army Medical Research and Materiel Command

  9/30/14 → 3/28/21

  Project: Research project

  • Zoledronic Acid
  • Spinal Cord Injuries
  • Biomarkers
  • Bone and Bones
  • Pharmaceutical Preparations
• Finished

  Increasing Bone Mass and Bone Strength in Individuals with Chronic Spinal Cord Injury: Maximizing Response to Therapy

  Schnitzer, T. J.

  U.S. Army Medical Research and Materiel Command

  9/30/16 → 3/29/19

  Project: Research project

  • Spinal Cord Injuries
  • Bone and Bones
  • Teriparatide
  • Alendronate
  • Therapeutics

• Prot #A4091056: A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Multicenter Study of the Analgesic Efficacy and Safety of a Dose Titration Regimen for the Subcutaneous Administration of Tanezumab in Subjects with Osteoarthritis of the Hip or Knee

  Schnitzer, T. J.

  INC Research, LLC, Pfizer Inc.

  8/2/16 → 8/2/19

  Project: Research project

• Cortico-striatal plasticity in the transition to chronic pain

  Griffith, J. W., Martina, M., Parrish, T. B., Procissi, D., Schnitzer, T. J., Surmeier Jr, D. J. & Apkarian, A.

  National Institute of Dental and Craniofacial Research

  7/1/16 → 12/31/18

  Project: Research project

• Brain mechanisms for clinical placebo in chronic pain

  Cella, D., Gershon, R., Griffith, J. W., Parrish, T. B., Schnitzer, T. J. & Apkarian, A.

  National Center for Complementary and Integrative Health

  6/1/16 → 5/31/18

  Project: Research project

• Prot #AXS02-K301: COAST-1: Clinical Knee Osteoarthritis Symptom Treatment 1 Study- A Randomized, Double-blind, Placebo-controlled Trial to Assess the Efficacy and Safety of AXS-02 (Disodium Zoledronate Tetrahydrate) Administered Orally to Subjects with Kn

  Schnitzer, T. J.

  Axsome Therapeutics, Inc.

  3/15/16 → 11/30/20

  Project: Research project